Direct patient care services provided by a pharmacist on a multidisciplinary renal transplant team

American Journal of Health-System Pharmacy

Volumn 57, Issue 21, 2000, Pages 1994-1996

  Chisholm, Marie A ^a,b   Vollenweider, Leslie J ^c   Mulloy, Laura L ^d   Jagadeesan, Muralidharan ^d   Wade, William E ^e   Dipiro, Joseph T ^d,e  

^a UNIVERSITY OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UGCP ^*

^d MCGSM   (United States)

^e UGACOP

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY CARE; DRUG MONITORING; HEALTH CARE DELIVERY; HEALTH SERVICE; KIDNEY GRAFT; MEDICAL CARE; NOTE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT MONITORING; PHARMACIST; PRIORITY JOURNAL;

EID: 0034329598     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/57.21.1994     Document Type: Note

References (17)

1. Sipes D. State, federal statutes guide organ donation procedures. Health Prog. 1987; 67:46.
2. 1999 annual report of the U.S. Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network. Transplant data: 1994-1998. Richmond, VA: United Network for Organ Sharing. 1999.
3. US Renal Data System. USRDS 1997 annual data report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 1997.
4. Leape LL, Cullen DJ, Clapp MD et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999; 282:267-70.
5. Bjornson DC, Hiner WO, Potyk RP et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm. 1993; 50:1875-84.
6. Montazeri M, Cook DJ. Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med. 1994; 22:1044-8.
7. Jameson J, VanNoord G, Vanderwoud K. The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract. 1995; 41:469-72.
8. Hanlon JT, Weinberger M, Samsa GP et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996; 100: 428-37.
9. Folli HL, Poole RL, Benitz WE et al. Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics. 1987; 79:718-22.
10. Strand LM, Morley PC, Cipolle RJ et al. Drug-related problems: their structure and function. Ann Pharmacother. 1990; 24:1093-7.
11. Hatoum HT, Hutchinson RA, Witte KW et al. Evaluation of the contribution of clinical pharmacists: inpatient care and cost reduction. Drug Intell Clin Pharm. 1988; 22:252-9.
12. Galt KA. Cost avoidance, acceptance, and outcomes associated with a pharmacotherapy consult clinic in a Veterans Affairs medical center. Pharmacotherapy. 1998; 18:1103-11.
13. Nicholson V, Johnson PC. Infectious complications in solid organ transplant recipients. Surg Clin North Am. 1994; 74(5):1223-45.
14. Laskow DA, Curtis JJ. Post-transplant hypertension. Am J Hypertens. 1990;3(9):721-5.
15. Curtis JJ. Management of hypertension after transplantation. Kidney Int Suppl. 1993; 43: S45-9.
16. Kirk JK, Dupuis RE. Approaches to the treatment of hyperlipidemia in the solid organ transplant recipient. Ann Pharmacother. 1995; 29:879-91.
17. Jindal RM. Post-transplant hyperlipidemia. Postgrad Med J. 1997; 73:785-93.